v3.26.1
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
REVENUE $ 485 $ 43
COST OF GOODS SOLD 264 0
GROSS PROFIT 221 43
OPERATING EXPENSES:    
Research and development expenses 424 312
Selling and marketing expenses 141 208
General and administration expenses 1,666 1,588
TOTAL OPERATING EXPENSES 2,231 2,108
OPERATING LOSS (2,010) (2,065)
OTHER INCOME (EXPENSE)    
Interest and bank fees (7) (128)
Interest income 14 0
Unrealized gain (loss) on foreign exchange (1) 3
Change in derivative fair value 0 (9,369)
Loss on settlement 0 (1,353)
Other income (expense), net 0 (18)
TOTAL OTHER INCOME (EXPENSE) 6 (10,865)
LOSS BEFORE INCOME TAX (2,004) (12,930)
Income tax provision 0 0
NET LOSS AND COMPREHENSIVE LOSS (2,004) (12,930)
Deemed dividend on warrant inducement 90 4,410
NET LOSS AND COMPREHENSIVE LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (2,094) $ (17,340)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (0.13) $ (1.74)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 16,227,346 9,956,933